Substance abuse disorders are among the most prevalent psychiatric disorders and are frequently comorbid with other psychiatric and health conditions and accompanied by social problems; however, they remain under-recognized and under-treated. Many physicians and mental health practitioners receive little-to-no training in the identification and treatment of these disorders. Approaches to their prevention include some of the major success stories in modern public health as well as some of the deepest controversies in public life. This new title in the WPA series Evidence and Experience in Psychiatry informs psychiatrists and a wide range of professional groups from health and social services about these disorders and their treatment and control.
Rezensionen / Stimmen
"This book provides a comprehensive review of substance abuse disorders by many of the world's leading experst in the field, and its contributors have a truly broad international representation. The chapters are clearly and authoritatively written, and each section is followed by commentaries that add the experience of experts to the evidence presented in the chapters." (Journal of Clinical Psychiatry, April 2012)
"The commentaries at the end of each section are pertinent and, at times, thought provoking. This book would be best appreciated by individuals with knowledge in this area, but will be educational for anyone interested in this topic." (Doody's, 21 October 2011)
"In this valuable contribution to the field, Ghodse (International Centre for Drug Policy, U. of London, UK) introduces a dozen chapters by international experts that address tobacco, alcohol, and other legal and illicit drugs." (Booknews, 1 April 2011)
Produkt-Info
Reihe
Auflage
Sprache
Verlagsort
Zielgruppe
Maße
Höhe: 24.4 cm
Breite: 16.8 cm
Dicke: 2.2 cm
Gewicht
ISBN-13
978-0-470-74510-6 (9780470745106)
Schweitzer Klassifikation
Hamid Ghodse is Professor of Psychiatry and International Drug Policy at St George's Hospital Medical School. He has been President of the International Narcotics Control Board since 2004, and a member of the board since 1992. Director of the International Centre for Drug Policy (UN) in Vienna. Editor of many books on addiction. He was appointed as inaugural Chair of the International Health Advisory Board in the UK in November 2009.
Helen Herrman is Director of the WHO Collaborating Centre in Mental Health, Melbourne. She has been Secretary of Publications for the World Psychiatric Association since 2005 She is also Regional Vice-President Oceania, World Federation for Mental Health, and Vice-President of the International Federation of Psychiatric Epidemiology.
Mario Maj is President of the World Psychiatric Association. Formerly he has been President of the Italian Psychiatric Association (since 2000); President of the Italian Society of Biological Psychiatry (since 1990); Secretary-General of the Association of European Psychiatrists (2001-2002); President of the Association of European Psychiatrists (2002).
Norman Sartorius is President of the International Association for the Promotion of Mental Health Programmes. Honorary Fellow of the Royal College of Psychiatrists of the United Kingdom of Great Britain, of the Royal Australian and New Zealand College of Psychiatrists and of the American College of Psychiatry; Distinguished Fellow of the American Psychiatric Association. Member of the WHO Expert Advisory Panel on Mental Health and a member of the WPA Council.
Herausgeber*in
St George's Medical School, London
University of Melbourne, Australia
University Of Naples
University of Geneva
List of Contributors.
Preface.
SECTION 1 DRUGS.
1 Epidemiology of Drug Abuse: A Global Overview (Maria-Elena Medina-Mora, Tania Real and Rebeca Robles).
2 Drug Abuse: Prevention (Vladimir B. Poznyak, James White and Nicolas Clark).
3 Drug Abuse: Treatment and Management (Fabrizio Schifano).
4 Commentaries.
4.1 Measuring, Preventing and Treating Global Drug Abuse (Kylie D. Reed, Mark Prunty and John Strang).
4.2 Epidemiology, Treatment and Prevention of Addictive Disorders (Pedro Ruiz).
4.3 The Global Challenge of Illegal Drugs (Neil McKeganey).
4.4 Drug Misuse - Lessons Learned Through the Modern Science (Igor Koutsenok).
4.5 An Integrated Approach to Drug-Abuse Treatment: The Role of Prevention (Abdu'l-Missagh Ghadirian).
4.6 Informing the Field of Substance Misuse: Progress and Challenges (David A. Deitch).
SECTION 2 ALCOHOL.
5 Epidemiology of Alcohol Abuse: Extent and Nature of the Problem (Jayadeep Patra, Andriy V. Samokhvalov and Jurgen Rehm).
6 The Prevention of Alcohol Problems (John B. Saunders and Noeline C. Latt).
7 Alcohol-Use Disorders - Treatment and Management (Filippo Passetti and Colin Drummond).
8 Commentaries.
8.1 Perverse Interpretation of Evidence in Alcohol Policy (Steve Allsop).
8.2 Implementing the Evidence Base (Duncan Raistrick).
8.3 Further Insights into the Burden of Alcohol Use on Mental Illness (Nady el-Guebaly).
8.4 Alcohol Issues - What Next? (Griffith Edwards).
8.5 The Evolving Global Burden of Disease from Alcohol (Joshua Tsoh and Helen Fung-Kum Chiu).
8.6 A Timely Review of Alcohol Related Disorders (Nasser Loza and Waleed Fawzi).
SECTION 3 TOBACCO.
9 Epidemiology of Tobacco Use (Ilana B. Crome and Marcus R. Munafo).
10 Tobacco Use: Prevention (Adriana Blanco, Vera da Costa e Silva and Maristela Monteiro).
11 Tobacco Abuse: Treatment and Management (Susanna Galea).
12 Commentaries.
12.1 Challenges in Reducing the Disease Burden of Tobacco Smoking (Coral Gartner and Wayne Hall).
12.2 Public Health and Tobacco Use (Pim Cuijpers).
12.3 Decreasing the Health Hazards of Tobacco: Necessary and Possible, But not Easy (Ahmad Mohit).
12.4 Overcoming State Addiction to Tobacco Industry (Robert West).
12.5 The Framework Convention on Tobacco Control: The Importance of Article 14 (Robyn Richmond).
12.6 Comments Regarding Epidemiology of Tobacco Use, Tobacco Use: Prevention and Tobacco Abuse: Treatment and Management (Yu Xin).
Index.
